Investment Analysts’ Updated EPS Estimates for June, 16th (ACN, AMZN, BAH, CRI, CYRX, FINL, IFF, IPGP, JCP, KITE)

Investment Analysts’ updated eps estimates for Friday, June 16th:

Accenture PLC (NYSE:ACN) had its outperform rating reiterated by analysts at Wells Fargo & Company. The firm currently has a $138.00 price target on the stock, up from their previous price target of $131.50.

Amazon.com (NASDAQ:AMZN) had its buy rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $1,150.00 price target on the stock.

Booz Allen Hamilton Holding Corporation (NYSE:BAH) had its outperform rating reaffirmed by analysts at Wells Fargo & Company. They currently have a $40.00 target price on the stock, down from their previous target price of $43.00.

Carter’s (NYSE:CRI) had its buy rating reiterated by analysts at FBR & Co. The analysts wrote, “We looked at the potential impact to CRI revenues due to Amazon and Skip Hop for 2017 and conclude that 2017 guidance is conservative with little upside included for both growth initiatives. We believe this provides a cushion to CRI guidance if traditional wholesale (dept stores, mass) is worse than expected (which we do not expect based on strong 1Q replenishment), and potential upside opportunity if the 1Q trends continue the rest of the year. CRI stock has been pressured by concerns over exposure to dept stores, but we believe this weakness is more than offset with Amazon/Skip Hop growth. Additionally, we believe 2Q is trending significantly better than 1Q based on solid spendtrend data for children’s (avg +6% in April/May) vs. -2.5% in 1Q17. We expect CRI to see multiple/stock expansion (CRI -15% over past year vs. SP500 +17%), as we believe CRI will report a strong 2Q (late July).””

Cowen and Company initiated coverage on shares of CryoPort (OTCMKTS:CYRX). They issued an outperform rating and a $5.50 target price on the stock.

The Finish Line (NASDAQ:FINL) had its neutral rating reaffirmed by analysts at Wedbush. Wedbush currently has a $15.00 price target on the stock.

Internationa Flavors & Fragrances (NYSE:IFF) had its hold rating reaffirmed by analysts at Stifel Nicolaus. They currently have a $136.00 price target on the stock, up from their previous price target of $129.00.

IPG Photonics Corporation (NASDAQ:IPGP) had its buy rating reiterated by analysts at Canaccord Genuity. They currently have a $152.00 price target on the stock, up from their previous price target of $138.00.

J.C. Penney Company, Inc. Holding Company (NYSE:JCP) had its underperform rating reissued by analysts at Credit Suisse Group. Credit Suisse Group currently has a $5.00 price target on the stock.

Kite Pharma (NASDAQ:KITE) had its underperform rating reissued by analysts at Wedbush. They currently have a $54.00 price target on the stock.

Kroger Company (The) (NYSE:KR) had its market perform rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $27.00 target price on the stock, down from their previous target price of $32.00.

Ngl Energy Partners Lp (NYSE:NGL) had its hold rating reaffirmed by analysts at Stifel Nicolaus. They currently have a $13.00 price target on the stock, down from their previous price target of $15.00.

Opko Health (NASDAQ:OPK) had its buy rating reiterated by analysts at Ladenburg Thalmann Financial Services. They currently have a $19.50 price target on the stock.

Redhill Biopharma (NASDAQ:RDHL) had its buy rating reaffirmed by analysts at FBR & Co. The analysts wrote, “BeiGene presented updated data at ICML from BTK inhibitor BGB-3111’s clinical.””

TransUnion (NYSE:TRU) had its overweight rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $48.00 target price on the stock, up from their previous target price of $45.00.

W.P. Carey (NYSE:WPC) had its market perform rating reissued by analysts at Wells Fargo & Company. The firm currently has a $69.00 price target on the stock, up from their previous price target of $59.50.

Xencor (NASDAQ:XNCR) had its outperform rating reiterated by analysts at Wedbush. They currently have a $29.00 target price on the stock.

Zions Bancorporation (NASDAQ:ZION) had its overweight rating reissued by analysts at Barclays PLC. They currently have a $50.00 price target on the stock, up from their previous price target of $48.00.

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/investment-analysts-updated-eps-estimates-for-june-16th-acn-amzn-bah-cri-cyrx-finl-iff-ipgp-jcp-kite/1915971.html

Receive News & Ratings for Accenture PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture PLC and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *